stopThymalin Peptide: Research-Grade Thymic Polypeptide Complex

Quick answer: Thymalin is the trade name for a complex of low-molecular-weight polypeptides isolated from calf thymus tissue, first developed in 1974 by Soviet researchers Morozov and Khavinson. Laboratory studies have investigated Thymalin as a thymic bioregulator affecting immune cell populations. This product is supplied exclusively for in-vitro laboratory research and is not licensed for human or veterinary use.

Sold strictly for laboratory and in-vitro research use. Not a medicine. Not for human or veterinary use or consumption. Not licensed under the Human Medicines Regulations 2012. Not assessed by the MHRA for safety or efficacy.

Anyone who has spent an evening cross-referencing a supplier’s HPLC trace against the batch number printed on the vial knows the drill: does the certificate actually belong to this lot, was it run on a reference standard or a house standard, and would the vendor still return your emails if the numbers didn’t add up? That vetting process is the real cost of sourcing thymic peptides for a research programme, and it’s a large part of why Thymalin peptide buyers tend to stick with suppliers once they’ve found one that publishes batch-specific data rather than a single stock certificate reused across every order.

What Is Thymalin?

Thymalin is not a single-sequence peptide but a polypeptide complex, extracted from bovine (calf) thymus tissue and originally isolated in 1974 by V. G. Morozov and V. Kh. Khavinson at the Kirov Military Medical Academy in Leningrad (Khavinson & Kuznik, 2013). It belongs to the broader family of “thymic bioregulators” studied for their effects on immune cell signalling. Because it is a mixture of related low-molecular-weight polypeptides rather than one defined molecule, Thymalin does not carry a single molecular formula the way a synthesised single-sequence peptide does — suppliers commonly reference CAS number 79621-14-0 as the registry identifier for the complex (Pharmaffiliates; ChemicalBook).

Research interest in thymic extracts like Thymalin sits within a wider field of investigation into thymus-derived polypeptides — including thymulin, thymosin alpha-1, and thymogen — each structurally distinct but grouped together in the literature for their overlapping study of immune cell regulation (Goldstein & Badamchian, 1998, Expert Opinion on Investigational Drugs).

What Current Research Says About Thymalin

Published research on Thymalin spans several decades of Russian and international literature, most of it examining immune cell populations and inflammatory markers in laboratory and clinical research settings rather than in consumer or over-the-counter contexts.

Immune cell population studies

A 2021 clinical study published in Advances in Gerontology (Springer Nature, 9 December 2021, Vol. 11, Issue 4, pp. 368–376) examined Thymalin administration in older hospitalised patients, comparing a Thymalin-treated group (n=36) against a standard-therapy control group (n=44). The study reported T-lymphocyte, B-lymphocyte and NK-cell counts increasing 2.2, 2.0 and 2.4-fold respectively relative to baseline, alongside a 6.5-fold reduction in interleukin-6 and a 3.3-fold reduction in C-reactive protein in the treated group, versus a 2.2-fold CRP reduction in controls (Advances in Gerontology, 2021). This is cited here as an example of the immunological parameters the compound class has been studied against — it is not a description of what any Synedica-supplied research material will do, and it does not establish safety or efficacy for any human application.

Thymic peptides as a research category

An earlier review in the peer-reviewed literature examined natural and synthetic thymic peptides — including thymic extracts in the Thymalin category — as subjects of ongoing investigation into immune dysfunction research models (Goldstein & Badamchian, 1998, Expert Opinion on Investigational Drugs, PMID: 9637345). This body of work is frequently referenced by later researchers profiling thymic bioregulators as a compound class rather than validating any single commercial product.

None of this research licenses Thymalin as a medicine in the United Kingdom, and none of it should be read as guidance for human or animal administration. Researchers using Thymalin in an in-vitro or laboratory setting should consult the primary literature directly and their own institution’s research governance framework.

Thymalin Specification & Comparison Table

Figures for shelf life and storage are general guidance for lyophilised polypeptide research material; always defer to the certificate of analysis and storage instructions issued with the specific batch received, as stability data varies by manufacturer and lot.

Purity & Certificate of Analysis Standards

A Thymalin batch is only as trustworthy as the paperwork behind it. Every batch supplied by Nexa Peptide Labs is issued with a lot-specific certificate of analysis showing the HPLC purity result, the reference standard used, and the batch number matching the vial label — not a generic specification sheet reused across unrelated shipments. Researchers should check that the batch number on any COA they’re sent matches the batch number physically printed on the vial before relying on the data (see our [internal: Certificate of Analysis page] for how to read a COA line by line).

Independent, third-party batch testing — rather than an in-house-only certificate — is the standard we’d recommend any researcher hold a supplier to, regardless of where they buy from.

Sourcing & Verification

Before adding any thymic polypeptide complex to a research order, it’s worth asking a supplier three direct questions: who performed the batch testing, is the COA specific to the lot being shipped, and what recourse exists if a batch doesn’t match its documentation. Nexa Peptide Labs publishes batch-matched COAs on request and welcomes researchers cross-checking results against independent laboratories. This product is intended for use by qualified researchers at recognised laboratory, academic, or research institutions, and purchasers are responsible for confirming their own institution’s research governance and import compliance requirements before ordering (see our [internal: research-use policy] page).

Storage & Handling

Lyophilised Thymalin should be stored at -20°C, kept desiccated and protected from light until use, consistent with standard handling for lyophilised polypeptide research material. Once reconstituted for in-vitro laboratory application, standard peptide research practice is to minimise freeze-thaw cycles and use reconstituted material promptly, working under appropriate laboratory conditions (sterile technique, correct PPE, and institutional biosafety protocols). Full handling and delivery details, including packaging and cold-chain information, are covered on our [internal: delivery and storage FAQ] page. This information describes laboratory handling of a research chemical — it is not instruction for human or animal administration.

Frequently Asked Questions

What is Thymalin peptide used for in research?

Thymalin is studied in laboratory and clinical research settings as a thymic polypeptide complex, primarily in relation to immune cell population changes and inflammatory markers. It is supplied by Nexa Peptide Labs strictly for laboratory and in-vitro research use, not for any therapeutic, cosmetic, or performance application.

Is it legal to buy Thymalin for research in the UK?

Research chemicals sold explicitly for laboratory and in-vitro use, and not represented as medicines, sit outside the licensing framework set out in the Human Medicines Regulations 2012. This product is not licensed as a medicine, has not been assessed by the MHRA, and must not be bought, sold, or used for human or veterinary application. Buyers are responsible for confirming their own institution’s compliance requirements.

Is Thymalin the same as Thymulin?

No. Thymalin (CAS 79621-14-0) is a polypeptide complex extracted from bovine thymus tissue, while Thymulin, also known as Facteur Thymique Sérique or FTS (CAS 63958-90-7), is a single defined nonapeptide. The two are frequently confused in retail listings because both are thymus-derived and studied in overlapping immunology research, but they are structurally distinct.

What does a Thymalin certificate of analysis show?

A proper COA shows the batch number matching the vial, the HPLC purity result, the reference standard the batch was tested against, the testing laboratory or method, and the date of analysis. It should be specific to the lot shipped, not a generic specification sheet.

How should Thymalin be stored, and what’s its shelf life?

Lyophilised Thymalin should be kept at -20°C, desiccated and protected from light. Shelf life is batch-dependent — always refer to the COA and storage instructions supplied with the specific lot, as stability data varies by manufacturer.

How is Thymalin different from an MHRA-licensed medicine?

An MHRA-licensed medicine has been through a formal marketing authorisation process assessing its safety, quality, and efficacy for a defined therapeutic use in humans. Thymalin as supplied here has not undergone that process in the UK, carries no licensed indication, and is sold exclusively for laboratory and in-vitro research — it is not a substitute for, and must not be treated as equivalent to, any licensed pharmaceutical product.

Does Nexa Peptide Labs offer independent third-party batch testing?

Yes. Batch-specific certificates of analysis are available on request, and we support researchers cross-checking results against an independent laboratory of their choosing.

What UK delivery and handling options are available for research orders?

Orders are dispatched with appropriate packaging and handling information for lyophilised polypeptide research material. Full delivery timelines, packaging, and cold-chain details are set out on our [internal: delivery and storage FAQ] page.

Can Thymalin be purchased by individuals, or only institutions?

This product is intended for purchase by qualified researchers and research-affiliated organisations for laboratory and in-vitro use only. It is not sold, marketed, or intended for personal, therapeutic, cosmetic, or performance use by consumers.

Where does the research on Thymalin come from?

Published research on Thymalin includes Russian-language and international peer-reviewed literature dating back to its original isolation in 1974, along with more recent clinical research such as a 2021 study in Advances in Gerontology examining immune cell parameters in a hospitalised patient population. Researchers should review primary sources directly rather than relying on secondary summaries.

What’s the difference between Thymalin and other thymic peptides like Thymosin Alpha-1 or Thymogen?

All are thymus-derived polypeptides studied in immunology research, but they differ structurally: Thymalin is a multi-peptide complex, Thymogen is a synthetic dipeptide (Glu-Trp) isolated from within the Thymalin complex, and Thymosin Alpha-1 is a distinct 28-amino-acid peptide with its own separate research literature. See our [internal: Thymosin Alpha-1 product page] for a structural comparison.